Author

Deblina Raychaudhuri

Indian Institute of Chemical Biology

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:cell signaling & trafficking· 2 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Abhinav K. JainiD· 1 shared Aminah J. Tannir· 1 shared Anurag Majumdar· 1 shared Asima MukhopadhyayiD· 1 shared Bidisha ChakrabortyiD· 1 shared Bidisha SinhaiD· 1 shared Byron Hing Lung LeeiD· 1 shared Chinky Shiu Chen LiuiD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Abhinav K. JainORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Loss of KDM6A-mediated genomic instability and metabolic reprogramming differentially regulates responses to immune checkpoint therapy and chemotherapy in bladder cancer.

Pratishtha Singh, Ranit D’Rozario, Bidisha Chakraborty, Swadhin Meher, Deblina Raychaudhuri, Aminah J. Tannir, Yang Li, Anurag Majumdar, Jessalyn Hawkins, Yun zhao Xiong, Philip L. Lorenzi, Padmanee Sharma, Kadir Caner Akdemir, Patrick Glen Pilie, Abhinav K. Jain, , Sangeeta Goswami

This study shows KDM6A mutations in bladder cancer improve response to immune checkpoint therapy but worsen chemotherapy outcomes through effects on DNA repair and metabolic reprogramming.

Nature Communications · Jan 7, 2026Peer-reviewedImmunology

Spatio-temporal regulation of ligand trafficking and TLR9 activation involves PIEZO1 mechanosensing in human plasmacytoid dendritic cells

Shrestha Pattanayak, Deblina Raychaudhuri, Purbita Bandopadhyay, Upasana Mukhopadhyay, Tithi Mandal, Chinky Shiu Chen Liu, Nidhi Kalidas, Sumangal Roychowdhury, Krishnananda Chattopadhyay, Fnu Ashish, Bidisha Sinha, Dipyaman Ganguly

This study identifies PIEZO1 mechanosensing as a key regulator of ligand-specific TLR9 signaling in human pDCs, showing that CpGA induces IFN production via membrane tension and PIEZO1 activation, while CpGB does not.

bioRxiv · Jul 31, 2025 · PreprintImmunology

Androgen receptor plays critical role in regulating cervical cancer cell migration

Sarpita Bose, Subhrangshu Das, Sebabrata Maity, Deblina Raychaudhuri, Tania Banerjee, Madhurima Paul, Asima Mukhopadhyay, Oishee Chakrabarti, Saikat Chakrabarti

This study identifies the androgen receptor as a key regulator in cervical cancer cell migration through network biology and experimental validation.

Molecular and Cellular Endocrinology · May 21, 2025Peer-reviewedCancer Biology